Napp Pharmaceuticals Ltd

Napp is a privately owned UK company with a strong track record in bringing high quality, innovative medicines to UK health professionals and their patients.

Napp provides prescription only medicines for respiratory diseases, such as asthma, inflammatory conditions, such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis
and psoriasis, as well as pain management, blood cancers and cardiovascular conditions.

Based in the heart of the Cambridge science community, and part of a worldwide network of independent associated companies across 48 countries, Napp prides itself on being an ambitious, asset led, customer-focused and sales driven organisation.

Visit website